Page last updated: 2024-10-30

mesalamine and Fetal Death

mesalamine has been researched along with Fetal Death in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nørgård, B1
Fonager, K1
Pedersen, L1
Jacobsen, BA1
Sørensen, HT1
Rahimi, R1
Nikfar, S1
Rezaie, A1
Abdollahi, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Sulfasalazine on CRH Levels in Pregnant Women With a History of Pre-Term Birth: A Randomized Controlled Trial[NCT05703425]Phase 250 participants (Anticipated)Interventional2023-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for mesalamine and Fetal Death

ArticleYear
Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
    Reproductive toxicology (Elmsford, N.Y.), 2008, Volume: 25, Issue:2

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal;

2008

Other Studies

1 other study available for mesalamine and Fetal Death

ArticleYear
Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
    Gut, 2003, Volume: 52, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis

2003